Transient elastography device sales will expand through 2036, with vibration controlled transient elastography holding 53.1% of the technology segment in 2026, driven by expanding diagnostic demand and growing adoption of non-invasive clinical assessment tools. The market was valued at USD 483.8 million in 2025 and is expected to be worth USD 1,071.9 million by 2036.